Sign Up to like & get
recommendations!
2
Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.1c06121
Abstract: The R132H mutation in the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) is the most important prognostic factor for the survival of glioma patients. Subsequent studies led to the discovery of a panel of enzymes mainly…
read more here.
Keywords:
cell;
metabolism;
r132h mutation;
cell cultures ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Immunology and Cell Biology"
DOI: 10.1111/imcb.12225
Abstract: Mutations in the isocitrate dehydrogenase (IDH) 1 gene, especially the R132H mutation, have been reported to be associated with a better prognosis in glioma patients. However, the underlying molecular mechanisms are not yet well understood.…
read more here.
Keywords:
idh1;
correlated better;
better prognosis;
r132h mutation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvaa018
Abstract: Abstract Context Mutations to isocitrate dehydrogenase (IDH) appear to play a prognostic or predictive role in several neoplasias. Immunohistochemical staining designed to detect a specific R132H mutation to IDH1 showed expression in the normal adrenal…
read more here.
Keywords:
carcinomas;
staining;
adrenocortical tumors;
r132h mutation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0169038
Abstract: Aim of study Mutations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) gene were recently discovered in vast majority of World Health Organization (WHO) grade II/III gliomas. This study is to understand the effects…
read more here.
Keywords:
idh1 r132h;
nadph gsh;
r132h mutation;
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Cancer"
DOI: 10.7150/jca.20665
Abstract: IDH1 R132H mutation is an important marker of survival in patients with gliomas. Although there are many changes of genes in tumour malignant progression, IDH1 R132H mutation status in glioma progression remained unclear. Here, an…
read more here.
Keywords:
r132h mutation;
progression;
idh1 r132h;
mutation ... See more keywords